Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective
Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective have?
Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective has 124 citations in the OpenAlex counts ScholarIQ stores.
When was Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective published?
Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective has 2020 year in the ScholarIQ index.
What is the open-access status of Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective?
Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective has closed oa status in the ScholarIQ index.
What is the DOI of Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective?
The DOI for Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective is on the source record.
What is the PMID of Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective?
The PMID for Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective is on the source record.
What is the OpenAlex record for Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective?
The OpenAlex for Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective is on the source record.